Immunizing Cancer Patients: Which Patients? Which Vaccines? When to Give?

被引:0
|
作者
Shah, Monika K. [1 ,2 ]
Kamboj, Mini [3 ,4 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Dept Med, Clin Med, New York, NY 10065 USA
[3] Weill Cornell Med Coll, Dept Med, Med, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Control Program, 1275 York Ave, New York, NY 10021 USA
来源
ONCOLOGY-NEW YORK | 2018年 / 32卷 / 05期
基金
美国国家卫生研究院;
关键词
PNEUMOCOCCAL POLYSACCHARIDE VACCINE; INTERNATIONAL TRAVEL PATTERNS; ZOSTER SUBUNIT VACCINE; DOSE INFLUENZA VACCINE; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; CONJUGATE VACCINE; UNITED-STATES; OLDER-ADULTS; TRANSPLANT RECIPIENTS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients receiving treatment for cancer should be considered for age- and indication-appropriate vaccinations, and the responsibility for administration of these vaccines is shared between the oncologist and the primary care provider. Certain vaccine-preventable diseases have higher incidence rates among cancer patients and are associated with worse clinical outcomes. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices recommend certain vaccines for routine use in adults, including those with cancer. This article provides guidance to oncology clinicians on vaccine recommendations and safety of use in their patients.
引用
收藏
页码:254 / +
页数:6
相关论文
共 50 条
  • [41] Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
    Sema Ciftci Dogansen
    Ozlem Soyluk Selcukbiricik
    Seher Tanrikulu
    Sema Yarman
    Pituitary, 2016, 19 : 303 - 310
  • [42] Which valued-based price when patients are heterogeneous?
    Levaggi, Rosella
    Pertile, Paolo
    HEALTH ECONOMICS, 2020, 29 (08) : 923 - 935
  • [43] Which drug, and when, for patients with BRAF-mutant melanoma?
    Jang, Sekwon
    Atkins, Michael B.
    LANCET ONCOLOGY, 2013, 14 (02): : E60 - E69
  • [44] Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
    Dogansen, Sema Ciftci
    Selcukbiricik, Ozlem Soyluk
    Tanrikulu, Seher
    Yarman, Sema
    PITUITARY, 2016, 19 (03) : 303 - 310
  • [45] Therapeutic Strategies: Which Treatment for Which Patients?
    Dematteis, M.
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2018, 20 : 19 - 19
  • [46] Tuberculosis testing: Which patients, which test?
    Elliott, Curt
    Hall, Jeff
    JOURNAL OF FAMILY PRACTICE, 2015, 64 (09): : 553 - 565
  • [47] WHICH HYPOCHOLESTEROLEMIC AGENTS FOR WHICH HYPERCHOLESTEROLEMIC PATIENTS
    DAIROU, F
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1990, 39 (10): : 591 - 595
  • [48] Antitachycardia pacing: Which patients and which methods?
    Rosenqvist, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 : 92 - 96
  • [49] ADJUVANT TREATMENT OF BREAST-CANCER - CHEMOTHERAPY AND HORMONAL TREATMENT - IN WHICH PATIENTS - WHEN - HOW
    GORINS, A
    CONTRACEPTION FERTILITE SEXUALITE, 1990, 18 (11): : 975 - 979
  • [50] When and for which patients does physician empathy improve cancer patient emotional quality of life?
    Lelorain, Sophie
    Cortot, Alexis
    Lordick, Florian
    Mehnert, Anja
    Cattan, Stephane
    Christophe, Veronique
    PSYCHO-ONCOLOGY, 2017, 26 : 6 - 6